Showing results (171-180 of 2,823) with videos related to
Sort By:
Pageof 283
Cytotherapy|September 16, 2005
Clinical and quality of life responses to high-dose chemotherapy plus autologous stem cell transplantation in patients with multiple sclerosis: two case reportsA A Novik, T I Ionova, G N Bisaga, et al.Cytotherapy|December 8, 2022
Mesenchymal stem/stromal cells from a transplanted, asymptomatic patient with Fanconi anemia exhibit an aging-like phenotype and dysregulated expression of genes implicated in hematopoiesis and myelodysplasiaChristopher L Haga, Siddaraju V Boregowda, Cori N Booker, et al.Cytotherapy|January 4, 2023
Assessment of anti-inflammatory bioactivity of extracellular vesicles is susceptible to error via media component contaminationStephanie M Kronstadt, Lauren Hoorens Van Heyningen, Amaya Aranda, et al.Cytotherapy|January 4, 2023
Prognostic impact of the simple L-index and absolute lymphocyte count early after allogeneic hematopoietic stem cell transplantationHiroyuki Kubo, Osamu Imataki, Tetsuya Fukumoto, et al.Cytotherapy|January 7, 2023
CRISPR/Cas9-mediated gene editing. A promising strategy in hematological disordersLaura Ugalde, Sara Fañanas, Raúl Torres, et al.Cytotherapy|December 30, 2022
Donor selection for adoptive cell therapy with CD45RA- memory T cells for patients with coronavirus disease 2019, and dexamethasone and interleukin-15 effects on the phenotype, proliferation and interferon gamma releaseKarima Al-Akioui-Sanz, Bárbara Pascual-Miguel, Mariana Díaz-Almirón, et al.Cytotherapy|July 3, 2021
Novel myeloperoxidase-derived HLA-A2-restricted peptides as therapeutic targets against myeloid leukemiaSijie Lu, Eran Tallis, Xiaoling Ding, et al.Cytotherapy|June 13, 2021
Transient blockade of TBK1/IKKε allows efficient transduction of primary human natural killer cells with vesicular stomatitis virus G-pseudotyped lentiviral vectorsPeter Chockley, Sagar L Patil, Stephen GottschalkCytotherapy|June 12, 2021
Decisional tool for cost of goods analysis of bioartificial liver devices for routine clinical useJoana Mendonça da Silva, Christos Stamatis, Sherri-Ann Chalmers, et al.Cytotherapy|May 24, 2022
Developing lisocabtagene maraleucel chimeric antigen receptor T-cell manufacturing for improved process, product quality and consistency across CD19+ hematologic indicationsJeffrey Teoh, Lauren F BrownPageof 283